TY  - JOUR
T1  - LAck of improvement in outpatient management of congestive heart failure in the united states
AU  - Banerjee D, Stafford RS
Y1  - 2010/08/09
N1  - 10.1001/archinternmed.2010.270
JO  - Archives of Internal Medicine
SP  - 1399
EP  - 1400
VL  - 170
IS  - 15
N2  - 
Congestive heart failure (CHF) accounts for 3% of admissions to US hospitals, and the diagnosis carries a mortality rate of 20% at 1 year and 80% at 8 years.1- 2 Numerous advances in the chronic medical management of CHF, including angiotensin antagonists, β-blockers, and aldosterone antagonists, have significantly reduced mortality in clinical trial populations with varying degrees of CHF severity.2- 4 Practices proven in clinical trials, however, do not always readily translate to community practice.5- 6 Previous studies in outpatient populations in the late 1990s through the early 2000s observed suboptimal adoption of evidence-based therapy for CHF. Using nationally representative data, we evaluated whether patterns of medication use have improved.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2010.270
UR  - http://dx.doi.org/10.1001/archinternmed.2010.270
ER  -